Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05605067 · ClinicalTrials.gov registry record
Genetic Architecture of Avoidant/Restrictive Food Intake Disorder
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 5,076
- Enrollment target
NCT05605067 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 5,076 participants.
The verdict
NCT05605067 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 5,076 participants
- Enrollment target
Study Summary
The goal of this observational study is to rapidly accelerate knowledge about the biology of avoidant and restrictive food intake disorder or ARFID in children ages 7-17 and in adults. The investigators will be evaluating the genetic and environmental origins of ARFID. Participants will be asked to answer questionnaires online and to submit a saliva sample for DNA using a kit that will be mailed to their home.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,076 participants |
| Start Date | 2023-01-05 |
| Est. Completion | 2024-08-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05605067
The ClinicalTrials.gov registry entry for NCT05605067 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 5,076 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05605067 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05605067 about?
NCT05605067 is a clinical study titled "Genetic Architecture of Avoidant/Restrictive Food Intake Disorder". The goal of this observational study is to rapidly accelerate knowledge about the biology of avoidant and restrictive food intake disorder or ARFID in children ages 7-17 and in adults. The investigators will be evaluating the genetic and environmental origins of ARFID. Participants will be asked to ...
What is the current status of trial NCT05605067?
This trial is currently completed. The enrollment target is 5,076 participants. The study started on 2023-01-05. Estimated completion is 2024-08-01.
Who is sponsoring clinical trial NCT05605067?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.